The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence of monoclonal gammopathy of undetermined significance in black South African men.
 
Kara Ilene Cicero
No Relationships to Disclose
 
Maureen Joffe
No Relationships to Disclose
 
Moosa Patel
Honoraria - Amgen; Novartis; Novo Nordisk; Roche; Takeda
Consulting or Advisory Role - Amgen; Novartis; Novo Nordisk; Takeda
Speakers' Bureau - Novartis; Novo Nordisk; Takeda
Travel, Accommodations, Expenses - South African National Blood Service
 
Audrey Pentz
No Relationships to Disclose
 
Paul Ruff
Speakers' Bureau - Amgen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Janssen Oncology (Inst); MSD (Inst); NantWorks (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Suzanne Lentzsch
Leadership - Caelum Biosciences
Stock and Other Ownership Interests - Caelum Biosciences
Consulting or Advisory Role - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Caelum Biosciences; Celularity; GlaxoSmithKline; Janssen; Sanofi; Sorrento Therapeutics; Takeda
Speakers' Bureau - Clinical Care Options; PeerView
Research Funding - Karyopharm Therapeutics; Sanofi
Patents, Royalties, Other Intellectual Property - Patent 11-1F4 mAb for use in AL Amyloidosis
Travel, Accommodations, Expenses - Janssen
 
Siyang Leng
Employment - Merck; Regeneron
Stock and Other Ownership Interests - Merck; Regeneron
Travel, Accommodations, Expenses - Merck; Regeneron
 
Codruta Chiuzan
No Relationships to Disclose
 
Judith Jacobson
No Relationships to Disclose
 
Timothy Rebbeck
Honoraria - AstraZeneca (I)
Consulting or Advisory Role - AstraZeneca (I)
 
Alfred I. Neugut
Leadership - EHE International
Stock and Other Ownership Interests - Stemline Therapeutics
Consulting or Advisory Role - EHE International; Eisai; GlaxoSmithKline; Otsuka; United Biosource Corporation
Research Funding - Otsuka (Inst)
Expert Testimony - Hospira